These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11514729)

  • 1. Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration.
    Vos A; Neubert A; Pommerening E; Müller T; Döhner L; Neubert L; Hughes K
    J Gen Virol; 2001 Sep; 82(Pt 9):2191-2197. PubMed ID: 11514729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine.
    Brown LJ; Rosatte RC; Fehlner-Gardiner C; Bachmann P; Ellison JA; Jackson FR; Taylor JS; Davies C; Donovan D
    Vaccine; 2014 Feb; 32(8):984-9. PubMed ID: 24374501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of maternal immunity on the immune response to oral vaccination against rabies in young foxes.
    Müller TF; Schuster P; Vos AC; Selhorst T; Wenzel UD; Neubert AM
    Am J Vet Res; 2001 Jul; 62(7):1154-8. PubMed ID: 11453495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine.
    Blasco E; Lambot M; Barrat J; Cliquet F; Brochier B; Renders C; Krafft N; Bailly J; Munier M; Pastoret PP; Aubert MF
    Vaccine; 2001 Sep; 19(32):4805-15. PubMed ID: 11535333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein.
    Tolson ND; Charlton KM; Casey GA; Knowles MK; Rupprecht CE; Lawson KF; Campbell JB
    Arch Virol; 1988; 102(3-4):297-301. PubMed ID: 3202696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
    Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of maternally transferred antibodies against rabies in foxes (Vulpes vulpes).
    Vos A; Schaarschmidt U; Muluneh A; Müller T
    Vet Rec; 2003 Jul; 153(1):16-8. PubMed ID: 12877212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The persistence of rabies virus antibodies in the sera of fox cubs.
    Hostnik P; Barlic-Maganja D; Toplak I; Grom J
    J Vet Med B Infect Dis Vet Public Health; 2003 May; 50(4):204-6. PubMed ID: 12916696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Abduraimov Y; Kondibayeva Z; Samoltyrova A; Amanova Z; Khairullin B; Sansyzbay A
    Arch Virol; 2017 Nov; 162(11):3363-3370. PubMed ID: 28766059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and efficacy of the oral rabies vaccine SAD B19 in foxes.
    Neubert A; Schuster P; Müller T; Vos A; Pommerening E
    J Vet Med B Infect Dis Vet Public Health; 2001 Apr; 48(3):179-83. PubMed ID: 11393813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1997 May; 71(5):3677-83. PubMed ID: 9094641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.
    Charlton KM; Artois M; Prevec L; Campbell JB; Casey GA; Wandeler AI; Armstrong J
    Arch Virol; 1992; 123(1-2):169-79. PubMed ID: 1550495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier.
    Xiang ZQ; Gao GP; Reyes-Sandoval A; Li Y; Wilson JM; Ertl HC
    J Virol; 2003 Oct; 77(20):10780-9. PubMed ID: 14512528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of animal recombinant DNA vaccine and its efficacy in foxes.
    Kieny MP; Blancou J; Lathe R; Pastoret PP; Soulebot JP; Desmettre P; Lecocq JP
    Rev Infect Dis; 1988; 10 Suppl 4():S799-802. PubMed ID: 3206090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a recombinant vaccinia-rabies vaccine for oral vaccination of foxes against rabies.
    Pastoret PP; Brochier B
    Dev Biol Stand; 1992; 79():105-11. PubMed ID: 1286744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.